EUVIMEDEUVIMED entdecken
Crossref

BMI1-induced CD127+KLRG1+ memory T cells enhance the efficacy of liver cancer immunotherapy

Shuai Wang, Nan Xu, Jianguo Wang, Yiyuan Chen, Wangyao Li, Huan Chen, Chenchen Shen, Chen Xu, Xuyong Wei, Di Lu, Nasha Qiu, Shusen Zheng und 2 weitere

Cancer Letters · 2023

DOI: 10.1016/j.canlet.2023.216336 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2023. Verfasst von Shuai Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Department of Hepatobiliary and Pancreatic Surgery, Affiliated H…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Polycomb Repressive Complex 1, Proto-Oncogene Proteins. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Hangzhou Municipal Health Commission, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The efficacy of HCC (hepatocellular carcinoma) immunotherapy is hindered by the limited reactivity and short duration of tumor-infiltrating T cells. These deficiencies may be ascribed to the proliferative ability of T cells. The primary objective of this study was to identify the key factor regulating tumor-infiltrating lymphocytes (TIL) proliferation within the HCC microenvironment. Through the utilization of tissue-infiltrated T cell proteomics and fraction proteomics, we analyzed the differential proteins in T cells among HCC, liver fibrosis, and hemangioma (serving as controls) groups. Additionally, we examined the differential regulatory TFs of T cells between the HCC and VH (volunteer healthy, as a control) groups. Using cyTOF and flow cytometry technologies, as well as generating CD8+ T-specific BMI1 knockout mice, we confirmed that BMI1 controls CD127+KLRG1+ memory cell differentiation. Through RNA-seq and MeRIP-seq, we verified that BMI1 regulates TCF1 expression independently of its classical function. Furthermore, by conducting Tyramide signal amplification (TSA) IHC analysis, employing a hydrodynamic mouse HCC model, and utilizing liver-specific nanoparticle targeting therapy, we demonstrated that BMI1 in HCC influences the proliferation of infiltrating CD8+T. BMI1 inhibition promotes effector T cell differentiation while suppressing memory T cell differentiation. Moreover, liver-specific BMI1 knockdown proves beneficial in ameliorating T cell dysfunction and decelerating HCC progression. Our research group has pioneered the exploration of the proteomics of HCC-infiltrated T cells, shedding light on the pivotal role of BMI1 in controlling CD127+KLRG1+ memory CD8+ T cell differentiation, which serves as the cornerstone for achieving immunotherapy efficacy in HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsPolycomb Repressive Complex 1Proto-Oncogene ProteinsAnimalsMiceCD8-Positive T-LymphocytesImmunotherapyMemory T CellsMice, KnockoutTumor Microenvironment

Stichwörter der Autor:innen

Esterase-responsive polymer (ERP)Hepatocellular carcinoma (HCC)N6-methyadeosine (m6A) modificationsTCF1Tumor-infiltrated T cells (TILs)

Substanzen

Bmi1 protein, mousePolycomb Repressive Complex 1Proto-Oncogene Proteins

Autor:innen und Institutionen

  • Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicin…
  • Zhejiang University School of Medicine, Hangzhou, 310058, China.
  • The Forth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
  • State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, China; Shulan (Hangzhou) Hospital, Zhejiang Shuren University School of Medicine, Hangzhou, 310022, China.

Förderung

  • Hangzhou Municipal Health Commission
  • National Natural Science Foundation of China

Zitieren

APA

Wang, S., Xu, N., Wang, J., Chen, Y., Li, W., Chen, H., Shen, C., Xu, C., Wei, X., Lu, D., Qiu, N., Zheng, S., Wei, Q., & Xu, X. (2023). BMI1-induced CD127+KLRG1+ memory T cells enhance the efficacy of liver cancer immunotherapy. Cancer Letters. https://doi.org/10.1016/j.canlet.2023.216336

Vancouver

Wang S, Xu N, Wang J, Chen Y, Li W, Chen H, et al. BMI1-induced CD127+KLRG1+ memory T cells enhance the efficacy of liver cancer immunotherapy. Cancer Letters. 2023. doi:10.1016/j.canlet.2023.216336

BibTeX
@article{Wang2023,
  author = {Wang, Shuai and Xu, Nan and Wang, Jianguo and Chen, Yiyuan and Li, Wangyao and Chen, Huan and Shen, Chenchen and Xu, Chen and Wei, Xuyong and Lu, Di and Qiu, Nasha and Zheng, Shusen and Wei, Qiang and Xu, Xiao},
  title = {BMI1-induced CD127+KLRG1+ memory T cells enhance the efficacy of liver cancer immunotherapy},
  journal = {Cancer Letters},
  year = {2023},
  doi = {10.1016/j.canlet.2023.216336}
}
Kostenlos starten →